2m 2m 2m 2m 2m 2m 2m
REGENXBIO (RGNX)
NASDAQ
$6.70+$0.18 (+2.68%)
Price as of Jun 03, 2026 7:30 PM EDT- $362.4MMarket Cap
- -35.64%1-Year Change
- BiotechnologyIndustry
REGENXBIO (RGNX)
$6.70+$0.18 (+2.68%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 156.3M +87.53% | 83.3M -7.66% | 90.2M -19.94% | 112.7M -76.03% | |
Cost of Revenue | N/A N/A | 33.6M -9.80% | 37.2M -31.78% | 54.5M +5.23% | |
Gross Profit | 156.3M +214.04% | 49.8M -6.16% | 53.0M -8.85% | 58.2M -86.10% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -228.3M +9.48% | -208.5M -10.22% | -232.3M -4.20% | -242.5M +33.63% | |
Depreciation and Amortization Expense | 15.6M -3.70% | 16.2M -6.38% | 17.3M +34.17% | 12.9M +34.97% | |
Total Operating Expenses | 331.6M +4.73% | 316.7M -11.63% | 358.4M -4.59% | 375.6M +21.02% | |
Operating Profit | -161.2M -30.92% | -233.3M -12.97% | -268.1M +2.00% | -262.9M -264.32% | |
Interest Income | 12.2M +0.83% | 12.1M N/A | N/A N/A | -79,000 -101.52% | |
Interest Expense | -192.5M 0.00% | -192.5M +2,705.30% | -6.9M -70.49% | -23.3M -11.50% | |
Interest Income and Expense and Net | -180.3M -0.06% | -180.4M +2,528.97% | -6.9M -70.59% | -23.3M +10.65% | |
Total Nonoperating Income and Expense | -32.7M -623.38% | 6.2M +39.31% | 4.5M +125.57% | -17.5M -6.43% | |
Income before Taxes | -161.2M -29.02% | -227.1M -13.86% | -263.6M -5.98% | -280.4M -298.52% | |
Income Taxes | 0 +100.00% | -152,000 0.00% | -152,000 +80.95% | -84,000 -100.63% | |
Extraordinary Items | 0 -100.00% | 2.1M N/A | 0 N/A | 0 N/A | |
Net Income | -193.9M -14.63% | -227.1M -13.81% | -263.5M -6.00% | -280.3M -319.27% | |
Net Income from Continuing Operations Applicable to Common | -193.9M -14.63% | -227.1M -13.86% | -263.6M -5.98% | -280.4M -298.52% | |
Basic EPS and Net Income | -3.76 -18.08% | -4.59 -23.75% | -6.02 -7.38% | -6.50 -315.95% | |
Diluted EPS and Net Income | -3.76 -18.08% | -4.59 -23.75% | -6.02 -7.38% | -6.50 -323.37% | |
Basic Weighted Average Shares | 51.6M +4.17% | 49.5M +13.20% | 43.7M +1.35% | 43.2M +1.68% | |
Diluted Weighted Average Shares | 51.6M +4.17% | 49.5M +13.20% | 43.7M +1.35% | 43.2M -1.73% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 34.5M -40.09% | 57.5M +66.64% | 34.5M -64.39% | 97.0M -71.91% | |
Short-Term Investments | 195.6M +10.41% | 177.2M -26.41% | 240.7M -10.07% | 267.7M +138.52% | |
Cash and Cash Equivalents and Short-Term Investments | 230.1M -1.97% | 234.7M -14.74% | 275.3M -24.51% | 364.6M -20.29% | |
Total Current Assets | 281.3M +1.18% | 278.0M -17.01% | 335.0M -19.47% | 416.0M -19.82% | |
Accumulated Depreciation | 87.2M +20.61% | 72.3M +26.37% | 57.2M +38.22% | 41.4M +42.54% | |
Property and Plant and Equipment and Net | 104.9M -10.83% | 117.6M -10.99% | 132.1M -6.76% | 141.7M +7.71% | |
Total Long-Term Assets | 4.6M +15.33% | 4.0M -16.79% | 4.8M -24.86% | 6.4M -0.48% | |
Total Assets | 453.0M -2.78% | 466.0M -18.81% | 574.0M -31.12% | 833.3M -25.19% | |
Income Taxes Payable | 5.7M -1.72% | 5.8M -29.27% | 8.2M -62.08% | 21.6M +90.95% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 400,000 N/A | |
Total Current Liabilities | 118.1M +14.44% | 103.2M -20.79% | 130.3M -0.12% | 130.4M -0.03% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 638,000 -82.45% | 3.6M -41.83% | 6.2M -29.25% | 8.8M +1,085.50% | |
Total Liabilities | 350.3M +69.77% | 206.3M -21.31% | 262.2M -17.30% | 317.1M -9.31% | |
Retained Earnings | -1.1B +20.80% | -932.1M +32.21% | -705.0M +59.67% | -441.6M +173.86% | |
Total Stockholders Equity | 102.7M -60.43% | 259.7M -16.71% | 311.7M -39.61% | 516.2M -32.46% | |
Total Shares Outstanding | 50.9M +2.71% | 49.5M +12.49% | 44.0M +1.73% | 43.3M +1.09% | |
Cash Flow | |||||
Cash from Operating Activities | -124.0M -28.40% | -173.1M -20.73% | -218.4M +5.26% | -207.5M -194.80% | |
Capital Expenditures | 2.4M -0.90% | 2.4M -75.54% | 10.0M -67.58% | 30.7M -63.50% | |
Cash from Investing Activities | -15.9M -115.34% | 103.4M -45.82% | 190.9M +1,700.66% | -11.9M -97.07% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 116.8M +25.99% | 92.7M +365.07% | -35.0M +21.24% | -28.8M -114.77% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | 59.72% +1.62% | 58.76% +13.86% | 51.61% -42.00% | |
Operating Margin | -103.16% -63.16% | -280.03% -5.75% | -297.12% +27.41% | -233.20% -785.63% | |
Return on Assets | -42.19% -3.40% | -43.68% +16.63% | -37.45% +30.06% | -28.79% -305.19% | |
Return on Equity | -107.00% +34.61% | -79.49% +24.89% | -63.65% +45.38% | -43.78% -295.57% | |
Revenue Growth | 87.53% +1,242.48% | -7.66% -61.59% | -19.94% -73.77% | -76.03% -137.22% | |
Current Ratio | 2.38 -11.59% | 2.69 +4.77% | 2.57 -19.37% | 3.19 -19.80% | |
Cash Ratio | 0.29 -47.66% | 0.56 +110.38% | 0.27 -64.35% | 0.74 -71.91% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow